Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)
13-006
Phase 2 small_molecule terminated
Quick answer
Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) for Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) is a Phase 2 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jazz Pharmaceuticals plc
- Indication
- Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated